[2026-11-02] Brain Thromboplastin, Biomarkers, and Coagulograms in Traumatic Brain Injury: Translating Pathophysiology Into Point-of-Care Practice
Research Medical Journal · 02.11.2026 · e279916
DOI: 10.33165/rmj.2028.e279916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Medical Journal, online erschienen am 02.11.2026. Verfasst von Supanadee Jianwittayakit und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Traumatic brain injury (TBI) is a leading cause of global morbidity and mortality, often complicated by coagulopathy. This narrative review explores how hemostatic disruption drives hemorrhagic progression or thromboembolic events, making early intervention crucial. A central mechanism is the release of tissue factor (TF), brain thromboplastin, from damaged neural tissue, which activates the extrinsic coagulation pathway to create a dynamic state of hypercoagulability, hypocoagulability, and fibrinolysis. These disturbances are further amplified by endothelial injury and brain-derived microparticles. While standard coagulograms and conventional biomarkers provide useful baselines, they lack TBI specificity and fail to capture evolving clot dynamics. Emerging biomarkers such as glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase L1 offer targeted early risk assessment, while viscoelastic testing provides real-time, functional evaluation of clot formation and lysis. Integrating these novel biomarkers with viscoelastic methods may help guide precise, goal-directed transfusion strategies. Future research must prioritize validating biomarker-driven algorithms, testing-guided therapies, and the targeted modulation of the TF pathway to optimize patient care
Zitieren
APA
Jianwittayakit, S., Sripunjan, K., Amornkornkijkul, A., & Vichitvejpaisal, P. (2026). [2026-11-02] Brain Thromboplastin, Biomarkers, and Coagulograms in Traumatic Brain Injury: Translating Pathophysiology Into Point-of-Care Practice. Research Medical Journal, e279916. https://doi.org/10.33165/rmj.2028.e279916
Vancouver
Jianwittayakit S, Sripunjan K, Amornkornkijkul A, Vichitvejpaisal P. [2026-11-02] Brain Thromboplastin, Biomarkers, and Coagulograms in Traumatic Brain Injury: Translating Pathophysiology Into Point-of-Care Practice. Research Medical Journal. 2026:e279916. doi:10.33165/rmj.2028.e279916
BibTeX
@article{Jianwittayakit2026,
author = {Jianwittayakit, Supanadee and Sripunjan, Krongthip and Amornkornkijkul, Alisa and Vichitvejpaisal, Phongthara},
title = {[2026-11-02] Brain Thromboplastin, Biomarkers, and Coagulograms in Traumatic Brain Injury: Translating Pathophysiology Into Point-of-Care Practice},
journal = {Research Medical Journal},
year = {2026},
pages = {e279916},
doi = {10.33165/rmj.2028.e279916}
}
EUVIMED